JPRN-UMIN000000947
Unknown
未知
Reversal of diabetes and prevention of arteriosclerosis in type 2 diabetic patients with oral antidiabetic agents - Pioglitazone and Sulfonylurea Remission from T2DM development and anti-atherosclerosis in Japan : PREVENT-J
PREVENT-J Study Steering Committee0 sites500 target enrollmentDecember 14, 2007
ConditionsType2 Diabetes Mellitus
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Type2 Diabetes Mellitus
- Sponsor
- PREVENT-J Study Steering Committee
- Enrollment
- 500
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •\-Heart failure or history of heart failure. \-EF of less than 40%. \-History of adverse reactions to a thiazolidine derivative or concerns about safety. \-Severe hepatic dysfunction. \-Severe renal dysfunction. \-History of cardiovascular disease. \-Current treatment with a sulfonylurea drug. \-Current treatment with a thiazolidine derivative. \-Current treatment with insulin. \-Those whom the principle investigator or other investigators consider unsuitable.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 2
Anti-platelet therapy for prevention of diabetic nephropathydiabetic nephropathyJPRN-UMIN000007718ational Hospital Organization Headquarters150
Active, not recruiting
Phase 3
Metformin treatment for diabetes prevention in AfricaISRCTN77382043niversity College London2,100
Completed
Not Applicable
A project to prevent the worsening of diabetic nephropathy in Kure city: A study of the effectiveness of the program to prevent the aggravation of CKDchronic kidney diseaseJPRN-UMIN000012407Hiroshima University, Graduate School of Biomedical and Health Sciences41
Active, not recruiting
Not Applicable
Religious leaders and diabetes prevention in BangladeshPrevention of diabetesNutritional, Metabolic, EndocrineISRCTN91564707Ministry of Health and Family Welfare824
Active, not recruiting
Not Applicable
Therapeutic Strategies of Prevention of Diabetes and Hypertension in Subjects with Metabolic Syndrome and High-Normal Blood Pressure. - PHIDIASHypertension, diabetes mellitus.MedDRA version: 6.1Level: SOCClassification code 10007541EUCTR2007-000947-88-ITISTITUTO AUXOLOGICO ITALIANO6,000